Loading…
← CockpitCompetitor Analysis › OPCH Option Care Health IncOpen in the cockpit ↗

Option Care Health IncOPCHCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Largest independent provider of home and alternate-site infusion therapy services in the United States.

Momentum leader 94
Mkt cap
$4.75B
US dollars, full cap
Free float
98%
of shares outstanding
$/day
$113M
20-day average traded
Fwd P/E
15.7×
forward earnings
ROIC−WACC
+4.7 pp
WACC 7.0%
Hurdle
-11 pp
Req g minus delivered
Next earnings
99 days
25 Feb 2027
Close · USD$31.71
1D+0.2%
1W0.0%
1M+1.1%
3M+35.0%
6M+42.6%
YTD-0.5%
1Y+12.8%
ATR %0.8%
Beta0.06
52w lowhigh13.8% off high

What Option Care Health does

Largest independent provider of home and alternate-site infusion therapy services in the United States.

Buys infusion drugs, supplies them to patients' homes and bills health insurers and government programmes for the drugs and the nursing visits that give them, so revenue is mostly drug cost while profit comes from a margin on top. It took its current form in 2019, when BioScrip merged with Option Care.

Products and services

  • Home infusion nursing services
  • Specialty infusion pharmacy
  • Chronic/acute infusion therapy management

Customers

  • Patients needing IV therapy at home
  • Referring physicians
  • Payers/health systems

Where it sits in the supply chain

  • Health care services
  • Home infusion therapy
  • Home/alternate-site infusion nursing…

What could go right

  • Shift of infusion care from hospital to home
  • Specialty drug infusion volume growth

What could go wrong

  • Payer reimbursement rate pressure
  • Nursing labor cost/staffing shortages

Moat: narrow (scale, distribution, regulatory licence). Largest national home-infusion network and payer contracts create scale hard for smaller regional providers to match.

Headquarters: Bannockburn, Illinois · Founded: 2015 · Employees: 6,528

Named competitors

Option Care Health at a glance

Size Option Care Health (OPCH) is a United States Health Care company (Medical/Nursing Services) with a market value of $4.75B, the 1214th largest of 3,085 United States companies the cockpit tracks. Shares closed at $31.71 on 18 Nov 2026.

Performance Over six months the shares gained 42.6%, against +21.3% for the median peer and -2.2% for the United States market (cap-weighted) — 6th highest of 20 in its peer set.

Growth Revenue grew 4.0% over the last twelve months (peer median +11.7%); the operating margin is 5.9% (peer median 9.4%).

Valuation It trades at 15.7× forward earnings against a peer median of 29.2× (5th cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is -11 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.7 points above its cost of capital (7.0% WACC).

Short interest Short interest is 4.1% of the free float (30 Oct 2026).

Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026OPCH 147Peer median 122
Six months, rebased to 100: Option Care Health against the median of its 20 peers (local-currency closes).

Option Care Health financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$5.75B$5.65B$5.00B$4.30B$3.94B
Revenue growth—+13%+16%+9%—
Gross profit$1.03B$1.02B$952M$922M$806M
EBITDA$412M$409M$385M$377M$325M
Net income$215M$208M$212M$267M$151M
Free cash flow$279M$217M$288M$329M$232M
Capital expenditure$40.5M$41.3M$35.6M$41.9M$35.4M
Total debt$1.26B$1.27B$1.22B$1.17B$1.16B

Quarterly statements and history in the cockpit →

Option Care Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%+150%-25%0%+25%BLLNLFSTCONHIMSRDNTMCOV-BLALPATHLABACHCSHL002044MDAVAHDVAAZTANEOOPCH6-month return →1-month return →
Up and to the right = strong over both horizons. Option Care Health is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%50×100×BLLNLFSTCONRDNTMCOV-BLALPATHLABACHCSHL002044MDAVAHALIF-BAZTANEOOPCHRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Option Care Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%75%3774BLLNLFSTCONRDNTMCOV-BLALPATHLABSHL002044MDALIF-BENSGAZTAOPCHGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Option Care Health is the large dot.

Option Care Health competitors and peer comparison

Head to head with its named competitors (OPCH vs CVS vs BTSG)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Option Care Health OPCH$4.75B+43%+4%6%15.7×2.0%
CVS Health CVS$104B-13%+7%4%9.6×-3.8%
BrightSpring Health Services BTSG$13.6B+17%+23%4%28.8×24.9%

How Option Care Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Option Care Health against its 20 peers (data as of 18 Nov 2026)
MeasureOPCHPeer medianRank in peer set
1-month return+1.1%+2.8%10th lowest of 21
6-month return+42.6%+21.3%6th highest of 20
Distance from 52-week high-13.8%-14.0%11th highest of 21
Revenue growth (TTM)+4.0%+11.7%6th lowest of 21
Operating margin5.9%9.4%5th lowest of 21
Forward P/E15.7×29.2×5th cheapest of 19
Growth the price implies (Req g, 7 yrs)2.0%12.7%4th least demanding of 18
Growth delivered (Del g)+13.2%+11.8%8th highest of 18
Hurdle (Req g minus delivered)-11.3 pp-1.5 pp2nd least demanding of 18
ROIC minus cost of capital+4.7 pp+0.8 pp6th highest of 21
EV / EBITDA13.9×13.7×9th cheapest of 17
Net debt / EBITDA2.3×2.9×8th least indebted of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Option Care Health OPCHUnited States$4.75B+43%+4%6%15.7×2.0%+13.2%
Fameglow 3774.HKHong Kong$4.54Bn/a+36%11%n/a57.4%+48.4%
BillionToOne BLLNUnited States$4.37B+7%+72%10%115.3×22.8%+71.9%
Lifestance Health LFSTUnited States$5.24B+79%+23%6%51.8×33.4%+30.4%
Concentra Group Holdings Parent CONUnited States$5.31B+65%+12%17%22.3×3.6%+7.9%
Hims & Hers Health HIMSUnited States$4.00B-26%+30%-1%n/an/an/a
RadNet RDNTUnited States$5.66B+32%+21%5%93.2×38.8%+13.7%
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
Sonic Healthcare SHL.AXAustralia$6.87B+6%+14%9%17.4×9.1%+3.5%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%
DaVita DVAUnited States$10.2B-18%+6%15%10.1×-2.5%+3.4%
AddLife ALIF-B.STSweden$2.13B+15%+2%8%39.0×21.1%+14.6%
Ensign ENSGUnited States$10.7B+3%+17%9%21.3×12.7%+16.5%
Azenta AZTAUnited States$2.03B+162%+5%-2%83.2×38.0%+3.9%
Fresenius Medical Care FME.DEGermany$11.2B+3%-1%11%9.5×-4.8%+1.9%
NeoGenomics NEOUnited States$1.98B+72%+11%-6%53.5×n/an/a

Questions

Who are Option Care Health's main competitors?
Named competitors: Amedisys (private or unlisted), CVS Health (Coram infusion) (CVS), BrightSpring Health Services (BTSG). The cockpit's measured peer set (industry) also includes Fameglow (3774.HK), BillionToOne (BLLN), Lifestance Health (LFST), Concentra Group Holdings Parent (CON), Hims & Hers Health (HIMS), RadNet (RDNT).
Is Option Care Health expensive compared with its peers?
On forward p/e it trades at 15.7× against a peer median of 29.2×, 5th cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 2% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is -11 pp: the price already allows for a slowdown.
How has Option Care Health stock performed?
Over six months to 18 Nov 2026 the shares returned +42.6% against +21.3% for the median peer; over one year +12.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.